Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
HURAthis companyTuHURA Biosciences, Inc.	$1.69	-1.2×	1.73×	0×	-1.14×	-100.8%	0.0%	0.0%	0.0%	-143.6%	-145.7%	-76.4%	0.03×	0.1×	-50.85×	0.78×	0.0%	1	-5.35	2	C
ABOSAcumen Pharmaceuticals, Inc.	$0.24	-1.06×	1.81×	0×	-0.9×	56.7%	0.0%	0.0%	0.0%	-172.3%	-121.7%	-90.5%	0.44×	0.19×	-29.32×	4.07×	0.0%	2	-11.67	2	C
AGENAgenus Inc.	$7.55	-923.53×	-0.34×	0.82×	6.84×	-468.1%	29.6%	-18.0%	0.1%	-0.0%	-34.5%	-170.2%	-1.24×	5.34×	-0.37×	0.41×	0.0%	6	-14.32	2	C+
CGTXCognition Therapeutics, Inc.	$0.73	-4.22×	2.87×	0×	-2.67×	-14.9%	0.0%	0.0%	0.0%	-68.5%	-136.9%	-25.0%	0.02×	1.56×	-3,676.85×	3.45×	0.0%	1	-0.97	2	C+
INOInovio Pharmaceuticals, Inc.	$1.41	-0.96×	3.39×	1,248.52×	-0.57×	-63.4%	100.0%	-132871.3%	-130000.0%	-352.5%	-259.4%	-109.0%	0.39×	0.43×	0×	1.4×	0.0%	0	-54.95	1	C-
IRDOpus Genetics, Inc.	$4.32	-2.51×	81.49×	88.1×	-25.08×	-106.9%	100.0%	-271.9%	-349.3%	-323.1%	-90.9%	-2.8%	0×	0.94×	-26.33×	6.43×	0.0%	3	-4.73	2	C
Peer median	—	-2.51×	2.87×	0.82×	-0.9×	-63.4%	29.6%	-18.0%	0.0%	-172.3%	-121.7%	-90.5%	0.02×	0.94×	-26.33×	3.45×	0.0%	2	-11.67	2	—